Geojit Financial Services research report on Apollo Hospitals Enterprise
Apollo Hospitals Enterprise Ltd. (Apollo) operates the largest network of about 73 hospitals and more than 6,000 pharmacies in India. In Q4FY24, consolidated revenue increased 15.1% YoY to Rs.4,972cr, driven by healthy performance across all segments. EBITDA surged 32.5% YoY to Rs. 669cr, with margins reaching to 13.4% (+170bps YoY) owing to higher topline and cost optimisation efforts. Apollo reported strong Q4 results with higher sales and improved margins. The company has been actively expanding its operations by adding new beds and hospitals, increasing surgical volumes, and broadening its test menu. These efforts are expected to boost the company's earnings potential in the future.
Outlook
Therefore, we upgrade our rating to BUY from HOLD on the stock with a revised target price of Rs. 7,059 based on a sum-of-the-parts (SOTP) valuation.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
